M. Skelsey

发表

Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study.

L. Ferris, B. Jansen, R. Moy, 2020, Journal of drugs in dermatology : JDD.

Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study.

D. Rigel, L. Ferris, S. Knezevich, 2019, Dermatology online journal.

Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions

L. Ferris, D. Siegel, G. Peck, 2018, Melanoma research.

Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden

B. Jansen, B. Brouha, L. Clarke, 2021, SKIN The Journal of Cutaneous Medicine.

Case Report and Review of Eccrine Porocarcinoma in Skin of Color

E. Dugan, M. Skelsey, Sadhana Sruveera Sathi, 2022, SKIN The Journal of Cutaneous Medicine.

Malignant Glomus Tumor Arising in a Long Standing Precursor Lesion.

A. Damavandy, F. Anatelli, M. Skelsey, 2016, The American Journal of dermatopathology.

Response to Marchetti et al.

J. Whitaker, B. Jansen, M. Howell, 2021, The Journal of investigative dermatology.

Genomic Atypia to Enrich Melanoma Positivity in Biopsied Lesions: Gene Expression and Pathology Findings From a Large U.S. Registry Study

L. Ferris, C. Cockerell, B. Jansen, 2021 .

Skin cancer risk is increased by somatic mutations detected noninvasively in healthy-appearing sun-exposed skin.

M. Skelsey, K. Kaur, R. Ai, 2024, The Journal of investigative dermatology.